- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, January 28, 2022
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by Becker's Hospital Review cited a study published in the January 2022 Health Information Technology (IT) special issue of The American Journal of Managed Care® (AJMC®). The study, “Understanding Physicians’ Work via Text Analytics on EHR Inbox Messages,” leveraged text analytics to identify work themes managed by primary care physicians in their electronic health record inbox messages and inform managers on workflow redesign. The study was also mentioned in a piece by EHRIntelligence.
A piece by mHealthIntelligence referenced another study published in the January 2022 Health IT special issue of AJMC®, titled “Addressing Virtual Care Disparities for Patients With Limited English Proficiency.” The study provided recommendations that address disparities for patients with limited English proficiency following the increase in use of virtual care due to the COVID-19 pandemic.
A study published online ahead of print from the July 2022 issue of AJMC®, titled “Projected US Savings From Biosimilars, 2021-2025,” was spotlighted in an article by HealthDay. Findings of the study indicated that projected savings from biosimilars from 2021 to 2025 were $38.4 billion vs conditions as of quarter 4 of 2020 and were driven by new biosimilar entry.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
